In this study, clinical characteristics, diagnosis and treatment processes of three synchronous MPLC cases diagnosed in our department were assessed
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Multiple primary lung cancers (MPLC) are named synchronous if determined simultaneously with the index tumor, and metachronous if the second tumor is diagnosed with an accepted time after the first tumor.
📊
Key Findings & Data:It is important for both the rate of survival and treatment alternatives to differentiate synchronous MPLCs from the metastases of the primary lung tumors, and also from the multiple pulmonary metastases of the extra pulmonary tumors.
💡
Conclusion & Impact:In this study, clinical characteristics, diagnosis and treatment processes of three synchronous MPLC cases diagnosed in our department were assessed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Multiple primary lung cancers (MPLC) are named synchronous if determined simultaneously with the index tumor, and metachronous if the second tumor is diagnosed with an accepted time after the first tumor. It is important for both the rate of survival and treatment alternatives to differentiate synchronous MPLCs from the metastases of the primary lung tumors, and also from the multiple pulmonary metastases of the extra pulmonary tumors. In this study, clinical characteristics, diagnosis and treatment processes of three synchronous MPLC cases diagnosed in our department were assessed
🔖
Cite This Article
TÜLEK, B., BABA, F., İNAN, E., KANAT, F., SÜERDEM, M. (2015). Synchronous, Multiple Primary Lung Cancers: A Report of Three Cases. Solunum, Cilt: 17 - Sayı: 1, 54–57. https://ajindex.com/articles/314504
Ferguson MK, DeMeester TR, DesLauriers J, Little AG, Piraux M, Golomb H. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg 1985; 89: 378-85.
Wu SC, Lin ZQ, Xu CW, Koo KS, Huang OL, Xie DQ. Multiple primary lung cancers. Chest 1987; 92: 892-6. [CrossRef] Carey FA, Donnelly SC, Walker WS, Cameron EW, Lamb D. Synchronous primary lung cancers: prevalence in surgical material and clinical impli- cations. Thorax 1993; 48: 344-6. [CrossRef] Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS; American Colle- ge of Physicians. Lung cancer. Special treatment issues. Chest 2003; 123: 244S-58S. [CrossRef] Hiraki A, Ueoka H, Yoshino T, Chikamori K, Onishi K, Kiura K, et al. Synch- ronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Oncol Rep 1999; 6: 75-80.
Kim YH, Lee KS, Primack SL, Kim H, Kwon OJ, Kim TS, et al. Small pul- monary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thorac Imaging 2002; 17: 40-6. [CrossRef] Yuan Y, Matsumoto T, Hiyama A, Miura G, Tanaka N, Emoto T, et al. The probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CT. Eur Radiol 2003; 13: 2447-53. [CrossRef] Arai J, Tsuchiya T, Oikawa M, Mochinaga K, Hayashi T, Yoshiura K, et al. Cli- nical and molecular analysis of synchronous double lung cancers. Lung Cancer 2012; 77: 281-7. [CrossRef] Dijkman BG, Schuurbiers OC, Vriens D, Looijen-Salamon M, Bussink J, Timmer-Bonte JN, et al. The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tu- mours. Eur J Nucl Med Mol Imaging 2010; 37: 2037-47. [CrossRef] Rosengart TK, Martini N, Ghosn P, Burt M. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg 1991; 52: 773-8. [CrossRef] Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998; 115: 836-40. [CrossRef] Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung can- cer. Ann Thorac Surg 1995; 59: 863-6. [CrossRef] van Rens MT, Zanen P, Brutel de La Riviere A, Elbers HR, van Swieten HA, van Den Bosch JM. Survival in synchronous vs. single lung cancer: upsta- ging better reflects prognosis. Chest 2000; 118: 952-8. [CrossRef] Jung EJ, Lee JH, Jeon K, Koh WJ, Suh GY, Chung MP, et al. Treatment out- comes for patients w